Primary Site >> Liver Cancer
Gene >> ANXA3
| 1. | |||||||||||
| Journal: | Cancer Chemother Pharmacol. 2008 Apr;61(5):791-802. | ||||||||||
| Title: | Proteomic analysis of liver cancer cells treated with suberonylanilide hydroxamic acid. | ||||||||||
| Author: | Tong, Aiping|Zhang, Haiyuan|Li, Zhengyu|Gou, Lantu|Wang, Zhi|Wei, Haiyan|Tang, Minghai|Liang, Shufang|Chen, Lijuan|Huang, Canhua|Wei, Yuquan | ||||||||||
| PMID: | 17593366 | ||||||||||
| 2. | |||||||||||
| Journal: | J Cell Biochem. 2012 May;113(5):1671-80. | ||||||||||
| Title: | Proteomic investigation of 5-fluorouracil resistance in a human hepatocellular carcinoma cell line. | ||||||||||
| Author: | Tong, Shi-Wen|Yang, Yi-Xuan|Hu, Huai-Dong|An, Xuan|Ye, Feng|Hu, Peng|Ren, Hong|Li, Sang-Lin|Zhang, Da-Zhi | ||||||||||
| PMID: | 22189913 | ||||||||||
| 3. | |||||||||||
| Journal: | Proteome Sci. 2012 Nov 21;10(1):69. | ||||||||||
| Title: | Label-free quantitative proteomics of CD133-positive liver cancer stem cells. | ||||||||||
| Author: | Tsai, Sheng-Ta|Tsou, Chih-Chiang|Mao, Wan-Yu|Chang, Wei-Chao|Han, Hsin-Ying|Hsu, Wen-Lian|Li, Chung-Leung|Shen, Chia-Ning|Chen, Chung-Hsuan | ||||||||||
| PMID: | 23170877 | ||||||||||
| 4. | |||||||||||
| Journal: | Am J Transl Res. 2017 Sep 15;9(9):4300-4307. eCollection 2017. | ||||||||||
| Title: | MicroRNA-205-5p regulates the chemotherapeutic resistance of hepatocellular carcinoma cells by targeting PTEN/JNK/ANXA3 pathway. | ||||||||||
| Author: | Shao, Ping|Qu, Wei-Kun|Wang, Cheng-Ye|Tian, Yu|Ye, Ming-Liang|Sun, De-Guang|Sui, Ji-Dong|Wang, Li-Ming|Fan, Rong|Gao, Zhen-Ming | ||||||||||
| PMID: | 28979703 | ||||||||||
| 5. | |||||||||||
| Journal: | J Hepatol. 2018 Oct;69(4):826-839. | ||||||||||
| Title: | Efficacy of annexin A3 blockade in sensitizing hepatocellular carcinoma to sorafenib and regorafenib. | ||||||||||
| Author: | Tong, Man|Che, Noelia|Zhou, Lei|Luk, Steve T|Kau, Phillis W|Chai, Stella|Ngan, Elly S|Lo, Chung-Mau|Man, Kwan|Ding, Jin|Lee, Terence K|Ma, Stephanie | ||||||||||
| PMID: | 29885413 | ||||||||||